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Abstract A novel peptide from Centruroides noxius Hoffmann
scorpion venom was isolated and sequenced. The 37 amino acid
peptide belongs to the charybdotoxin sub-family (KKTx1) and
was numbered member 11. KKTx1.11 has 75% sequence identity
with iberiotoxin and 54% with charybdotoxin. KKTx1.11
revealed specificity for mammalian MaxiK channels (hSlo),
thus, was named slotoxin. Slotoxin blocks the MaxiK pore-
forming K subunit reversibly (Kd = 1.5 nM). Slotoxin association
with K+L (L1 or L4) channels was V10 times slower than
iberiotoxin and charybdotoxin, leading to a lack of effect on
K+L4 when tested at 100 nM for 5 min. Thus, slotoxin is a better
tool to distinguish MaxiK K+L complexes. ß 2001 Federation
of European Biochemical Societies. Published by Elsevier Sci-
ence B.V. All rights reserved.
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1. Introduction
The large-conductance voltage and calcium-activated potas-
sium (MaxiK, BK) channels are intrinsic membrane proteins
that regulate excitability in a large variety of tissues including
brain and smooth muscle [1]. MaxiK can be formed only by
K subunits or by complexes with at least four families of
L subunits [2^5]. The K subunit (Slo) is formed by the ‘core’
that includes transmembrane segments S0^S6 and hydropho-
bic regions S7^S8, the C-terminal ‘tail’ containing S9^S10,
and the linker that binds both domains [6]. The ‘core’ contains
the voltage sensor, the pore region and the site for L1 subunit
interaction [7^9]. The pore is formed by the loops of amino
acid sequences between the ¢fth and sixth membrane spanning
domains, and is the place where permeation of ions occur, and
where many pharmacologically active peptides bind [10]. Co-
expression with L subunits (with two transmembrane domains
and a large extracellular loop) modi¢es the MaxiK K-subunit
kinetic behavior, Ca2 sensitivity, modulation, and pharmaco-
logical properties like scorpion toxin sensitivity [5,11^15].
Scorpion venoms are rich sources of peptides, which have a
variety of pharmacological e¡ects on ion channels. Of special
interest are those that a¡ect ionic membrane permeability
[10,16] as they have been excellent tools to study ion channel
function and structure [17]. About 50 di¡erent peptides from
scorpion venoms were recently revised and classi¢ed within 12
sub-families, based mainly on structural similarities [18]. All
of these peptides have between 23 and 42 amino acid residues.
They have in common an K-helix, two or three anti-parallel
L-sheets, and three or four disul¢de bridges that shape the
three-dimensional structure and are essential for channel rec-
ognition [19]. Most scorpion toxins speci¢c for K channels
are known to behave as pore blockers. The a⁄nity of a given
toxin for di¡erent types or sub-types of K channels can vary
several orders of magnitude [16,17].
Here we describe a new scorpion toxin KKTx1.11 (slotoxin
(SloTx)) that speci¢cally inhibits mammalian MaxiK channels
and is capable of di¡erentiating among three types of com-
plexes, K, K+L1 and K+L4.
2. Materials and methods
2.1. Chemicals, venom and puri¢cation procedure
All chemicals were analytical grade reagents obtained from sources
already described [20,21]. Scorpions of the species Centruroides noxius
were milked for venom in the laboratory. The crude venom was dis-
solved in distilled water and spun at 10 000Ug for 15 min. The super-
natant was separated by column (0.9U190 cm) Sephadex G-50 gel
¢ltration, followed by high-performance liquid chromatography
(HPLC) using a semi-preparative C18 reverse-phase column (Vydac,
Hisperia). Several independent runs of HPLC were obtained. The
active fraction was further separated in an analytical C18 reverse-
phase column using a di¡erent gradient (see legend to Fig. 1).
2.2. Amino acid sequence
The amino acid sequence was obtained by automatic Edman deg-
radation in a LF3000 Protein Sequencer (Beckman) [20]. Samples of
approximately 1 nmol each of native toxin or reduced and alkylated
toxin were applied to the sequencer. A sample of peptide was also
cleaved by cyanogen bromide (CNBr) after N-terminal blockade and
sequenced. The last amino acid was elucidated by mass spectrometry
analysis. The molecular masses were obtained on a Voyager DE-PRO
(PerSeptive Biosystems) equipped with a nitrogen laser (337 nm) [22].
2.3. Electrostatic potential analysis
Electrostatic potentials were obtained after homology modeling and
energy minimization using parameters of charybdotoxin (ChTx) solu-
tion structure (Swiss-Prot Accession No. 2CRD), Swiss-Model and
Deep View (Swiss-Pdb Viewer) [23] (http://www.expasy.ch/spdv/).
2.4. Electrophysiological measurements
cRNA for hSlo (human MaxiK K subunit), dSlo (Drosophila Max-
iK K subunit), Herg, IRK, Kv1.1, ShIR, SK1, SK2 and SK3 K sub-
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units and MaxiK L1 and L4 subunits were synthesized using mMES-
SAGE mMACHINE In Vitro Transcription Kit (Ambion). cRNA
were injected into Xenopus oocytes using 1^2 ng of K subunits, and
when appropriate, with V20-fold molar excess of L subunits. These
conditions have shown a saturating e¡ect of the L subunit on the
Ca2-sensitivity of MaxiK K subunit [4,13]. Potassium currents were
recorded 2^7 days after RNA injection.
2.4.1. Two-electrode voltage-clamp. The bath solution was ND-96
(mM): 96 NaCl, 2 KCl, 1.8 CaCl2, 1 MgCl2, 5 HEPES, pH 7.0, with
NaOH, or modi¢ed ND-96 (containing 30 mM KCl and 68 NaCl).
Resistance for the voltage and current electrodes were 0.3^0.5 and
1.0^1.5 M6, respectively, when ¢lled with 3 M KCl. Holding poten-
tials were: 390 mV for Herg, 380 mV for ShIR and Kv1.1, and 0 mV
for IRK2.1. Pulses were from 380 to +80 in 10 mV steps. For Herg,
post-test potential was to 3120 mV. Macroscopic currents were re-
corded using the CA1B ampli¢er (Dagan Corporation). Currents were
¢ltered at 1/5 of the sampling frequency.
2.4.2. Outside-out patches. Pipet and bath solutions contained
(mM): 110 K-methanesulfonate, 5 KCl, 10 HEPES, 5 N-(2-hydroxy-
ethyl)ethyl-enediaminetriacetic acid, pH 7.0. Di¡erent free intracellu-
lar Ca2 solutions were prepared by addition of CaCl2 according to
the Chelator program [24] and adjusted using a calcium-selective elec-
trode (World Precision Instruments). Patch pipets had resistances of
2^4 M6. Holding potential was 0 mV for dSlo, hSlo, SK1, SK2 and
SK3. An EPC-7 ampli¢er (List Medical) and pCLAMP software
(Axon Instruments) were used for acquisition and analysis. Bovine
serum albumin (0.001%) was present in all toxin and washing solu-
tions.
2.4.3. Curve ¢tting. Pharmacological experiments were ¢tted as-
suming a bimolecular reaction. Association (kon) and dissociation
(koff ) rates, and equilibrium dissociation constants (Kd) were obtained
as described before [5]. Values are mean þ S.D.
3. Results and discussion
3.1. Isolation and characterization of the new toxin, KKTx1.11
Three distinct fractions (Fig. 1a, I, II and III) were obtained
after separation of C. noxius soluble venom on a Sephadex
G-50 column. Only fraction II was capable of inhibiting
MaxiK currents assayed at 30 Wg/ml protein. Fraction II
was further puri¢ed by HPLC in a C18 semi-preparative col-
umn yielding a complicated pattern of separation (Fig. 1b).
To facilitate identi¢cation of active peptides, the HPLC out-
put was pooled into six fractions II.1 to II.6 (horizontal bars,
labeled 1 to 6). Only fraction II.2 blocked MaxiK currents
(n = 3). This fraction contained about 22 di¡erent components
(Fig. 1b, left-side inset), but only component 22 had MaxiK
channel activity (n = 3). Therefore, component number 22
(asterisk) was further puri¢ed to homogeneity (Fig. 1b,
right-side inset).
The puri¢ed peptide was directly sequenced and the ¢rst
36 amino acid residues were unequivocally identi¢ed (Fig.
1c, arrow marked with d). The presence of a Met in position
29 facilitated CNBr cleavage of the peptide. The N-terminal
amino acid was alkylated before CNBr cleavage. Sequence
determination of the C-terminal peptide con¢rmed the se-
quence of the last seven residues (Fig. 1c, arrow marked
with CNBr). The last residue was obtained by mass spectrom-
etry analysis (Fig. 1c, arrowhead marked with MS). The
native peptide had a molecular mass of 4082.82. The ¢rst
36 residues accounted for a mass of 3983.83, taking into con-
sideration the three disul¢de bridges typical of MaxiK block-
ing toxins [19]. The missing amino acid residue of the se-
quence should have a molecular mass of 99.01, which
corresponds exactly to that of valine. Thus, it is very likely
that the full amino acid sequence of this peptide contains
37 amino acid residues.
Sequence comparison using BLASTP showed that the pu-
ri¢ed peptide has a greater similarity with the ChTx sub-fam-
ily, KKTx1, than to other sub-families of the short-chain
KKTx family from scorpion venoms [18]. The new toxin is
closely related to limbatustoxin (LbTx; KKTx1.4) [25] with
84% identity, and to iberiotoxin (IbTx; KKTx1.3) with 76%
identity. The identity with ChTx (KKTx1.1) was only 54%
(Fig. 2a). We decided to classify this new toxin, KKTx1.11,
Fig. 1. Puri¢cation and sequence of KKTx1.11 (SloTx). a: Three
fractions (I^III) were obtained after the soluble C. noxius venom
(80 mg) was separated in a Sephadex G-50 column using 20 mM
ammonium acetate bu¡er, pH 4.7. b: The active fraction (II) was
further separated by HPLC, using a semi-preparative C18 reverse-
phase column, with a linear gradient of solution A (0.12% tri£uoro-
acetic acid/water) to 60% of solution B (0.10% tri£uoroacetic acid/
acetonitrile). Left-side inset: Fraction II.2 was run in an analytical
C18 reverse-phase column with a linear gradient from 5% to 40% so-
lution B in 90 min. Right-side inset: Re-chromatography of compo-
nent 22 (labeled with asterisk in the left-side inset). Pure peptide
corresponds to less than 0.5% of the soluble venom. c: Amino acid
sequence obtained by direct sequencing of the native peptide (d),
CNBr cleaved peptide, and mass spectrometry analysis (MS). Ar-
rows mark the sequence obtained by each method.
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according to the international nomenclature proposed recently
by Tytgat et al. [18]. Consistent with its sequence similarity to
LbTx, IbTx and ChTx, KKTx1.11 is also a potent inhibitor of
the mammalian MaxiK channel K subunit (Slo) (see Fig. 3),
and thus, was given the common name, SloTx.
Multiple sequence alignment of SloTx with LbTx, IbTx and
ChTx shows that the C-terminal region from position 25, in-
cluding two L-sheets [25], is the most conserved region across
the molecules (Fig. 2a). In addition, electrostatic potential
analysis, at 120 mM ionic strength, demonstrates that similar
to IbTx and ChTx, the conserved C-terminal region of SloTx
confers to the molecule a positive electrostatic isopotential
that is very close to the molecular surface. For illustrative
purposes, Fig. 2b shows the electrostatic isopotentials at
zero ionic strength, which makes clear that SloTx has a sur-
face that is positively charged (blue grid). These results are
consistent with the fact that SloTx blocks MaxiK channels
(see Fig. 3) and the view that the positively charged C-termi-
nal domain is a major component for speci¢c short-range
interactions between scorpion toxins and the negatively
charged pore region of K channels leading to channel block-
ade [26^29]. Speci¢c hydrophobic residue^residue interactions
between SloTx and MaxiK channels may also contribute to
toxin^channel interaction as is the case for ChTx [26]. Inter-
estingly, the N-terminal £anking region of the K-helix and
prior to the L-sheet is similar in SloTx and IbTx, but distinct
in ChTx (Fig. 2a). This region is situated in the face opposite
to the site of toxin^pore interaction [29], and might have
implications for the modulation of channel blockade by the
MaxiK L subunits (see below).
3.2. A⁄nity of KKTx1.11 for the MaxiK channel K subunit
The two-electrode voltage-clamp technique was used during
the toxin isolation procedure to measure the activity of di¡er-
ent fractions on the MaxiK K subunit (hSlo) currents. As
mentioned before, fraction II and sub-fractions II.2 and
II.2.22 all had a blocking e¡ect on the MaxiK currents.
The blocking kinetics of the pure peptide (KKTx1.11,
SloTx) was determined in outside-out patches expressing the
MaxiK K subunit (hSlo) and under conditions to attain a high
channel open probability (84 WM [Ca2]i ; +40 mV) [13]. Ad-
dition of 100 nM SloTx blocked more than 90% of the current
(Fig. 3a), which was completely blocked by 10 mM tetraeth-
ylammonium (TEA). Toxin blockade reached steady-state
within 15^30 s and was fully reversible (Fig. 3a, wash). Fig.
3d shows the normalized current before (1), after addition of
toxin (2), and after washout (3) (arrows mark the addition of
toxin and the beginning of washout). The data could be well
¢tted assuming a bimolecular blocking reaction (continuous
line). To increase the accuracy of kon measurements, addition-
al experiments with a lower SloTx concentration (10 nM) were
performed. kon was (3.9 þ 2.2)U106 M31 s31, koff was
(4.8 þ 1.7)U1033 s31, and Kd was 1.5 þ 0.8 nM (n = 5). kon
and koff values of SloTx are close to those reported for
IbTx, but one order of magnitude smaller than the ones for
ChTx [5]. The results suggest that SloTx, similar to IbTx and
ChTx, interacts with the MaxiK channel pore-forming K sub-
unit by blocking the pore via a bimolecular reaction.
3.3. L subunit modulation of the SloTx^MaxiK K subunit
interaction
It is known that co-expression of MaxiK accessory L sub-
units change the voltage and Ca2 sensitivities, the kinetics,
and the pharmacology of the MaxiK channel pore-forming
K subunit [11,14]. Thus, we decided to explore whether the
smooth muscle L1 subunit [30] or neuronal L4 subunit [5]
modify the pattern of SloTx blockade of MaxiK channels.
To con¢rm L subunit expression, voltage^activation curves
were obtained in all experiments (insets in panels a,b,c). At
the calcium concentration tested (V90 WM), L1 caused a left-
Fig. 2. Molecular characteristics of KKTx1.11 (SloTx). a: Amino acid sequence comparison of SloTx, LbTx, IbTx and ChTx. Toxins were
aligned using the Pileup program (Genetics Computer Group). Dashes: Identical residues; question mark: unknown residue. Amino acids form-
ing K-helix and L-strands in IbTx (dashed line) and ChTx are marked [25,31]. b: Predicted electrostatic isopotential of SloTx, IbTx and ChTx.
Red surfaces represent negative electrostatic isopotentials at a free energy of 32 kT/e; the blue surfaces are for positive isopotentials of
+2 kT/e. Molecules are oriented such that the bottom part would interact with the pore of K channels [27^29].
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ward shift of V85 mV of the voltage^activation curves,
whereas L4 caused a shift of V39 mV. Half activation poten-
tials were: 22 þ 13 mV (n = 5) for the K subunit, 362 þ 8 mV
(n = 5) for K+L1 subunits and 317 þ 23 mV (n = 4) for K+L4
subunits.
Co-expression of the L1 subunit (Fig. 3b,c) slowed down
the on-rate of channel blockade by two orders of magnitude
to (5 þ 2.8)U104 M31 s31 (n = 5) when compared with the
K subunit alone (3.9 þ 2.2)U106 M31 s31. In addition, the
o¡-rate was dramatically slowed down making SloTx block-
ade practically irreversible during the experimental time
(Fig. 3e; n = 5). Fig. 3b illustrates control records (1), after
V10 min of toxin application (2), and V15 min following
washout (3). It also shows that L1 co-expression does not
a¡ect full blockade by 10 mM TEA. Interestingly, if channel
blockade was not allowed to reach steady-state, washout in-
duced V50% of recovery (not shown; n = 2), which may be
indicative of a second binding step between the channel, the
toxin and the extracellular loop of the L1 subunit. Thus, the
bimolecular model used to ¢t the data is only an approxima-
tion and Kd values cannot be estimated.
In the case of oocytes co-expressing K+L4 subunits (Fig.
3c,f), the association rate of the toxin was much slower than
when L1 was co-expressed. The on-rate was decreased by four
orders of magnitude to (5.9 þ 1)U102 M31 s31 (n = 4) when
compared to the K subunit alone. On the other hand, the o¡-
rate was even slower, making the toxin dissociation irrevers-
ible within the experimental time (V30 min following wash-
out; Fig. 3f). Because of the drastic diminution in the associ-
ation rate, the toxin concentration was increased to 1 WM to
be able to evaluate the on-rate within a reasonable time frame
(V25 min; Fig. 3f). Traces in Fig. 3c illustrate the current
blockade after V25 min of toxin application (2), V30 min
following toxin washout (3), and complete blockade with 10
mM TEA. Fig. 3g illustrates the magnitude of K, K+L1 and
K+L4 blockade using the same concentration of SloTx (100
nM), 5 min after toxin application. Due to the extreme slow
on-rate of SloTx on K+L4 channels, their blockade is imper-
ceptable in this time range, whereas blockade of channels
assembled by K+L1 or K subunits was V90%. In other words,
K+L4 channels are extremely resistant to SloTx blockade, but
once blocked, the toxin interaction is apparently irreversible.
Experiments using L1 and L4 demonstrate that SloTx bind-
ing to the channel is 10 times slower than the interaction of
Fig. 3. Blocking properties of KKTx1.11 on MaxiK channels formed by K or K+L complexes. Outside-out patches from Xenopus oocytes ex-
pressing K (a,d), K+L1 (b,e) and K+L4 (c,f) subunits. Currents were elicited at +40 mV from a holding potential of 0 mV every 2 s. a,b,c: Cur-
rent traces at speci¢c times during the experiment. Numbers in traces (a,b,c) and in time^course plots (d,e,f) are equivalent. 1: Control; 2: in
presence of toxin; 3: after toxin washout. TEA blockade was performed before toxin application. Arrows mark the time of addition of toxin
and washout. d,e,f : Steady-state current amplitudes as a function of time. The gray line is the best ¢t to a bimolecular blocking reaction, which
is only an approximation for K+L1 and K+L4 channels. g: Normalized current obtained after 5 min application of 100 nM SloTx to channels
formed by K, K+L1 and K+L4. Note that the L4 subunit makes MaxiK channels extremely resistant to SloTx blockade.
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IbTx and ChTx with the channel when these subunits are
present [5]. In fact, 100 nM SloTx is unable to signi¢cantly
block the channel within 5 min of application in K+L4 chan-
nels (Fig. 3g), whereas IbTx or ChTx block V20% of the
current in this same time frame [5]. Thus, SloTx is a more
reliable pharmacological tool than ChTx or IbTx to distin-
guish channels formed by MaxiK K+L4 complexes.
3.4. Speci¢city of KKTx1.11 toxin for MaxiK channels
The toxin speci¢city was assayed in di¡erent types of
K channels such as the voltage-dependent ShIR (Shaker
K channel with inactivation removed), Kv1.1, and Herg;
the voltage- and calcium-activated hSlo and dSlo; the volt-
age-independent/calcium-activated SK1, SK2 and SK3; and
the voltage-independent IRK2.1. The two-electrode voltage-
clamp system was used to study all voltage-dependent
K channels and IRK2.1. Outside-out patches were used to
study all calcium-dependent K channels. None of these
channels showed any type of inhibition when nanomolar con-
centrations of SloTx were tested (Table 1) and after 10 min of
toxin application. The lack of activity of SloTx towards the
K channel types examined here mimics the IbTx inactivity
on channels other than the MaxiK channels. Thus, IbTx and
the new toxin reported here (SloTx, KKTx1.11) are quite spe-
ci¢c for MaxiK channels.
In summary, our results open the possibility to use
KKTx1.11 for discriminating channels in di¡erent tissues
that express K, K+L1 or K+L4 channels.
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Table 1
Speci¢city of KKTx1.11 toxin for MaxiK channels
Channel 9[SloTx] (nM) Inhibition
hSloa 200 +
dSloa, Kv1.1b, Hergb or IRK2.1b 300 3
ShIRb 350 3
SK1a, SK2a or SK3a 500 3
aOutside-out patches and 110 K-methanesulfonate.
bTwo-electrode voltage-clamp and ND96 or modi¢ed ND96.
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